Drug Profile
Research programme: renal disease therapeutics - Nektar Therapeutics
Alternative Names: NKTR-228Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Nektar Therapeutics
- Class
- Mechanism of Action Hormone inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Kidney disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Kidney-disorders in USA
- 18 Apr 2012 Early research in Kidney disorders in USA (unspecified route)